Oxford Pharmaceuticals Calls for National Security Focus on Generic Drugs

WASHINGTON–(BUSINESS WIRE)–Tom Neely, chairman of Oxford Pharmaceuticals, testified Wednesday before the U.S. Senate Special Committee on Aging, urging Congress to recognize generic pharmaceuticals as critical national security infrastructure and implement policies that would enable domestic manufacturers to compete against heavily subsidized foreign producers.

Oxford operates one of America’s few remaining facilities engaged in domestic generic pharmaceutical manufacturing, transforming raw ingredients into finished medicines.

“I want to thank Chairman Scott and Ranking Member Gillibrand for their bipartisan leadership on this critical issue and their commitment to solutions that will protect American seniors,” Neely said. “Their focus on label transparency and supply chain security reflects what our aging population deserves-clarity about where their medicines come from and confidence in their safety.”